Inhibition of Rat Liver Mitochondrial Monoamine Oxidase by Hydrazine-thiazole Derivatives: Structure-activity Relationships
Overview
Affiliations
The purpose of this research is to study the relationship between chemical structure and inhibitory activity of some hydrazine-thiazole derivatives on rat liver mitochondria monoamine oxidase (MAO). Forty-five compounds belonging to three series of hydrazine-thiazole derivatives, with either alkylic or arylic substituents in the thiazole ring, were tested. The highest inhibitory activity was observed with piperonyl derivatives 25 and 40, which contain a 4-methyl group in the thiazole nucleus. The structure-activity relationship of MAO inhibitors was established in relation to hydrophobic, electronic and steric hindrance parameters. A mechanism of enzyme inhibition was proposed based on the calculation of HOMO energies.
Osmani Ye D, Saglik B, Levent S, Cevi K U, Ilgin S, Yurttas L ACS Omega. 2024; 9(10):11388-11397.
PMID: 38496951 PMC: 10938434. DOI: 10.1021/acsomega.3c07703.
Shrimp J, Jing Y, Thalalla Gamage S, Nelson K, Han J, Bryson K ACS Med Chem Lett. 2021; 12(6):887-892.
PMID: 34141066 PMC: 8201477. DOI: 10.1021/acsmedchemlett.0c00193.
Saglik B, Cebeci O, Acar Cevik U, Osmaniye D, Levent S, Kaya Cavusoglu B Molecules. 2020; 25(18).
PMID: 32971892 PMC: 7571065. DOI: 10.3390/molecules25184342.
Tau as a therapeutic target in neurodegenerative disease.
Himmelstein D, Ward S, Lancia J, Patterson K, Binder L Pharmacol Ther. 2012; 136(1):8-22.
PMID: 22790092 PMC: 3697479. DOI: 10.1016/j.pharmthera.2012.07.001.